Asfalia Biologics
Gene therapy development
- B2B
About Asfalia Biologics
A biotechnology company focused on developing safe gene transfer strategies for gene therapy
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2018
- Revenue
- $3.5M – $27.4MTamtam estimate
Asfalia Biologics at a glance
Asfalia Biologics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Asfalia Biologics was founded in 2018.
Asfalia Biologics has 1–10 employees.
Asfalia Biologics's revenue is $3.5M – $27.4M (Tamtam estimate).
Frequently asked questions about Asfalia Biologics
What is Asfalia Biologics's revenue?
Tamtam estimates Asfalia Biologics's annual revenue at $3.5M – $27.4M.
How many employees does Asfalia Biologics have?
Asfalia Biologics has 1–10 employees.
Where is Asfalia Biologics headquartered?
Asfalia Biologics is headquartered in Paris, Île-de-France, France.
Selling to companies like Asfalia Biologics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies